vs
FEDERAL AGRICULTURAL MORTGAGE CORP（AGM）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是FEDERAL AGRICULTURAL MORTGAGE CORP的1.8倍（$197.9M vs $107.5M），REPLIGEN CORP同比增速更快（13.6% vs 6.1%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 7.1%）
联邦农业抵押贷款公司（又称Farmer Mac）是由美国国会1988年依据《1987年农业信贷法案》设立、由股东持股的联邦特许企业，核心业务是搭建农业不动产及住房抵押贷款的二级市场，提升农业领域的信贷流动性，为农户、牧场主及乡村社区提供长期稳定的信贷支持。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
AGM vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.8倍
$107.5M
营收增速更快
RGEN
高出7.5%
6.1%
两年增速更快
RGEN
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.5M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 56.3% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 6.1% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $3.69 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGMRGEN
| Q4 25 | $107.5M | $197.9M | ||
| Q3 25 | $104.0M | $188.8M | ||
| Q2 25 | $102.6M | $182.4M | ||
| Q1 25 | $94.3M | $169.2M | ||
| Q4 24 | $101.3M | $174.1M | ||
| Q3 24 | $90.3M | $154.9M | ||
| Q2 24 | $89.9M | $154.1M | ||
| Q1 24 | $93.7M | $151.3M |
净利润AGMRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $55.0M | $14.9M | ||
| Q2 25 | $54.8M | $14.9M | ||
| Q1 25 | $49.7M | $5.8M | ||
| Q4 24 | $56.5M | $-30.3M | ||
| Q3 24 | $49.8M | $-654.0K | ||
| Q2 24 | $47.1M | $3.3M | ||
| Q1 24 | $53.7M | $2.1M |
毛利率AGMRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率AGMRGEN
| Q4 25 | 56.3% | 9.0% | ||
| Q3 25 | 64.1% | 8.9% | ||
| Q2 25 | 63.8% | 7.6% | ||
| Q1 25 | 66.9% | 3.9% | ||
| Q4 24 | 67.5% | -17.7% | ||
| Q3 24 | 69.0% | -5.1% | ||
| Q2 24 | 65.9% | 1.0% | ||
| Q1 24 | 72.8% | 1.3% |
净利率AGMRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 52.9% | 7.9% | ||
| Q2 25 | 53.4% | 8.2% | ||
| Q1 25 | 52.6% | 3.4% | ||
| Q4 24 | 55.8% | -17.4% | ||
| Q3 24 | 55.2% | -0.4% | ||
| Q2 24 | 52.4% | 2.2% | ||
| Q1 24 | 57.4% | 1.4% |
每股收益（稀释后）AGMRGEN
| Q4 25 | $3.69 | $0.24 | ||
| Q3 25 | $4.44 | $0.26 | ||
| Q2 25 | $4.48 | $0.26 | ||
| Q1 25 | $4.01 | $0.10 | ||
| Q4 24 | $4.62 | $-0.55 | ||
| Q3 24 | $3.86 | $-0.01 | ||
| Q2 24 | $3.68 | $0.06 | ||
| Q1 24 | $4.28 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $30.8B | $542.2M |
| 股东权益账面价值 | $1.7B | $2.1B |
| 总资产 | $35.4B | $2.9B |
| 负债/权益比越低杠杆越低 | 17.93× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资AGMRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | $842.1M | $784.0M | ||
| Q2 24 | $923.0M | $809.1M | ||
| Q1 24 | $745.1M | $780.6M |
总债务AGMRGEN
| Q4 25 | $30.8B | $542.2M | ||
| Q3 25 | $29.2B | $537.9M | ||
| Q2 25 | $28.9B | — | ||
| Q1 25 | $28.0B | — | ||
| Q4 24 | $27.5B | $525.6M | ||
| Q3 24 | $27.2B | — | ||
| Q2 24 | $26.8B | — | ||
| Q1 24 | $26.8B | — |
股东权益AGMRGEN
| Q4 25 | $1.7B | $2.1B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.5B | $2.0B |
总资产AGMRGEN
| Q4 25 | $35.4B | $2.9B | ||
| Q3 25 | $33.4B | $2.9B | ||
| Q2 25 | $33.0B | $2.9B | ||
| Q1 25 | $31.8B | $2.9B | ||
| Q4 24 | $31.3B | $2.8B | ||
| Q3 24 | $30.6B | $2.8B | ||
| Q2 24 | $30.2B | $2.9B | ||
| Q1 24 | $29.8B | $2.8B |
负债/权益比AGMRGEN
| Q4 25 | 17.93× | 0.26× | ||
| Q3 25 | 17.31× | 0.26× | ||
| Q2 25 | 18.70× | — | ||
| Q1 25 | 18.39× | — | ||
| Q4 24 | 18.48× | 0.27× | ||
| Q3 24 | 18.60× | — | ||
| Q2 24 | 17.87× | — | ||
| Q1 24 | 18.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | 0.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流AGMRGEN
| Q4 25 | $80.1M | $25.7M | ||
| Q3 25 | $74.2M | $48.1M | ||
| Q2 25 | $-47.7M | $28.6M | ||
| Q1 25 | $-49.8M | $15.0M | ||
| Q4 24 | $612.6M | $39.2M | ||
| Q3 24 | $-44.4M | $49.3M | ||
| Q2 24 | $56.1M | $42.2M | ||
| Q1 24 | $233.3M | $44.7M |
自由现金流AGMRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $607.4M | $33.6M | ||
| Q3 24 | $-44.4M | $42.3M | ||
| Q2 24 | $52.6M | $37.4M | ||
| Q1 24 | $231.7M | $36.4M |
自由现金流率AGMRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | 599.8% | 19.3% | ||
| Q3 24 | -49.2% | 27.3% | ||
| Q2 24 | 58.5% | 24.3% | ||
| Q1 24 | 247.3% | 24.0% |
资本支出强度AGMRGEN
| Q4 25 | 0.0% | 4.1% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.0% | 2.1% | ||
| Q4 24 | 5.2% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 4.0% | 3.1% | ||
| Q1 24 | 1.7% | 5.5% |
现金转化率AGMRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.35× | 3.23× | ||
| Q2 25 | -0.87× | 1.92× | ||
| Q1 25 | -1.00× | 2.57× | ||
| Q4 24 | 10.84× | — | ||
| Q3 24 | -0.89× | — | ||
| Q2 24 | 1.19× | 12.70× | ||
| Q1 24 | 4.34× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
